Pfiz­er ac­cused of Covid-19 vac­cine patent in­fringe­ment again, this time by Ar­bu­tus and Genevant

Ar­bu­tus has ac­cused Pfiz­er and BioN­Tech of in­fring­ing its lipid nanopar­ti­cle tech­nol­o­gy patents in de­vel­op­ing their block­buster mR­NA Covid-19 vac­cine.

While Ar­bu­tus and Genevant Sci­ences …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER